Kennebec Savings Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-356
Closed -$9.89K 250
2025
Q3
$9.89K Buy
+356
New +$9K 0.01% 215

Other funds holding ARKG

Kennebec Savings Bank's ARKG Position: Q4 2025 in Review

Kennebec Savings Bank sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 356 shares — an estimated $9.89K sold.

Kennebec Savings Bank first reported a position in ARKG in Q3 2025 and held it in 1 quarter. The position peaked at $9.89K in Q3 2025. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Kennebec Savings Bank reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Kennebec Savings Bank sold 356 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $9.89K.
  • Kennebec Savings Bank first reported a position in ARK Genomic Revolution ETF in Q3 2025 and held it in 1 quarter.
  • Kennebec Savings Bank's ARK Genomic Revolution ETF position peaked at $9.89K in Q3 2025.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Kennebec Savings Bank's 13F filing for Q4 2025, filed 22 Jan 2026.